Meet BrosMed at EUROPCR 2023
Release time:
2023-04-18
We’re excited to announce that BrosMed team will attend EuroPCR 2023 – the world’s largest cardiovascular event, from May 16th to May 19th in Paris, France.
We’re excited to announce that BrosMed team will attend EuroPCR 2023 – the world’s largest cardiovascular event, from May 16th to May 19th in Paris, France. As a company committed to improving clinic outcomes through innovative medical devices, we look forward to connecting with industry experts, clinicians, and researchers at this premier conference.
EuroPCR offers a unique opportunity to exchange ideas, share knowledge, and set up the network with fellow professionals in the field of cardiovascular intervention. We’ll be showcasing our latest cardiovascular products and solutions, and we’re eager to learn from and collaborate with you.
By visiting our booth, you will gain new insights into the BrosMed Medical innovative cardiovascular intervention products including:
POT™ PTCA NC Balloon Dilatation Catheter: Dedicated Balloon for POT and DOT Technique
Alveo™ HP CTO Balloon Dilatation Catheter: Smallest ø 0.75mm CTO Balloon in the world
Wedge™ NC Scoring Balloon Dilatation Catheter: Safe and controlled lesion preparation
Pronavi™ Microcatheter: Two low-profile options: 1.7F &1.9F, 135cm length for antegrade, 150cm & 162cm length for retrograde
Our Booth No. is M42 (Level-2-hall-maillot). Please contact us via email: sales@brosmed.com if you are planning on participating in this leading congress. We are delighted to meet you there and get inspiration of technology and innovation from each other. See you at EuroPCR 2023!
About BrosMed Medical
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), two manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 40 product series and 360+ products registration certificates in worldwide.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
